Role of Medicinal Plants in Liver Disease Management
Main Article Content
Abstract
Medicinal plants have played a vital role in healthcare systems worldwide since ancient times and continue to be an important source of therapeutic agents.they contain a wide range of bioactive compounds.liver disease or hepatic disease is any disturbance, inflammation or damage to the liver that prevents it from performing its essential functions. liver diseases,.Several medicinal plants, including Silybum marianumL(milk thistle), picrorhizakurroa(kutkiL), Phyllanthus emblica(amlaL), Phyllanthus niryriL, glycyrrhiza glabraL(licorice)etc. Herbal medicine played an important role in Ayurveda, an Indian medical tradition that developed over thousands of years. the Charaka Samhita and Sushruta Samhita described numerous medicinal plants and their applications.Traditional Chinese medicine used plants and other natural substances for treating various health conditions.
References
1.Thyagarajan S, Jayaram S, Gopalakrishnan V, Hari R, Jeyakumar P, Sripathi M. Herbal medicines for liver diseases in India. Journal of Gastroenterology and Hepatology. 2002 Dec;17:S370–6.
2. Arman M, Chowdhury KAA, Bari MdS, Khan MF, Huq MMdA, Haque MdA, et al. Hepatoprotective potential of selected medicinally important herbs: evidence from ethnomedicinal, toxicological and pharmacological evaluations. Phytochemistry Reviews. 2022 Mar 22;21(6):1863–86.
3.SahuP, ChhabraP, Mehendale AM, Acomprehensive Review on non-alcoholic Fatty liver disease.
4. Kazemi S, shidfar F, Ehsani S, Adibi P, JananiL, Eslami O. The effects of sumacL. Powder supplementation in patients with non-alcoholic fatty liver disease.
5. Li B, Xi Y, Liu YP, Wang D, Wang C, Chen C, et al. Effects of Silybum marianum, Pueraria lobate, combined with Salvia miltiorrhiza tablets on non-alcoholic fatty liver disease in adults: A triple-blind, randomized, placebo-controlled clinical trial.
6. Siegel AB, Narayan R, Rodriguez R, Goyal A, Jacobson, DrPH JS, Kelly K, et al. A Phase I Dose-Finding Study of Silybin Phosphatidylcholine in Patients With Advanced Hepatocellular Carcinoma.
7. Han L, Wang Y, Sun S. Curcumin inhibits proliferation of hepatocellular carcinoma cells through down regulation of DJ-1.
8. Sharma B, John S. Hepatic cirrhosis [Internet]. National Library of Medicine. StatPearls Publishing; 2022.
9. Nusrat S, Khan MS, Fazili J, Madhoun MF. Cirrhosis and its complications:
Evidence based treatment. World Journal of Gastroenterology 2014 May 14;20(18):5442–60.
10.Duval F, Moreno-Cuevas JE, González-Garza MT, Maldonado-Bernal C, Cruz-Vega DE. Liver Fibrosis and Mechanisms of the Protective Action of Medicinal Plants Targeting Inflammation and the Immune Response.
11.Arbab AH, Parvez MK, Al-Dosari MS, Al-Rehaily AJ. In vitro evaluation of novel antiviral activities of 60 medicinal plants extracts against hepatitis B virus. Experimental and Therapeutic Medicine [Internet].
12. Latief U, Ahmad R. Herbal remedies for liver fibrosis: A review on the mode of action of fifty herbs. Journal of Traditional and Complementary Medicine [Internet]. 2018 Jul [cited 2019 May 6];8(3):352–60.
13.Amin ZA, Alshawsh MA, Kassim M, Ali HM, Abdulla MA. Gene expression profiling reveals underlying molecular mechanism of hepatoprotective effect of Phyllanthus niruri on thioacetamide-induced hepatotoxicity in Sprague Dawley rats. BMC Complementary and Alternative Medicine. 2013 Jul 5;13(1).
14. Fried MW. Effect of Silymarin (Milk Thistle) on Liver Disease in Patients WithChronic Hepatitis C Unsuccessfully Treated With Interferon Therapy. JAMA. 2012 Jul 18;308(3):274.
15. Wah Kheong C, Nik Mustapha NR, Mahadeva S. A Randomized Trial of Silymarin for the Treatment of Nonalcoholic Steatohepatitis.
16.Kim NC, Graf TN, Sparacino CM, Wani MC, Wall ME. Complete isolation and characterization of silybins and isosilybins from Silybum marianum Electronic supplementary information ESI
17. Luangchosiri C, Thakkinstian A, Chitphuk S, Stitchantrakul W, Petraksa S,
10
Sobhonslidsuk A. A double-blinded randomized controlled trial of silymarin for the prevention of antituberculosis drug-induced liver injury. BMC Complementary and Alternative Medicine.
18. Sultan P, Jan A, Pervaiz Q. Phytochemical studies for quantitative estimation of iridoid glycosides in Picrorhizakurroa Royle. Botanical Studies. 2016 Feb 26
19. Dong P, Gao Z, Yin X, Li Z, Han H. Hepatoprotective activity assessment of amino acids derivatives of picroside I and II. Chemical Biology & Drug Design. 2020 Sep 23
20. Hassan, Said M,Zalwani Zainuddin, Omar H, Ali, Aris SA, et al. Effects of one-year supplementation with Phyllanthus niruri on fibrosis score and metabolic markers in patients with non-alcoholic fatty liver disease
21. Harish R, Shivanandappa T. Antioxidant activity and hepatoprotective potential of Phyllanthus niruri. Food Chemistry. 2006 Mar;95(2):180–5.
22. Kleiner D, Hegyi G, Urbanics R, László Dézsi, Robotka H, Erzsébet Fehér, et al. Hepatoprotective liposomal glycyrrhizin in alcoholic liver injury. European Journal of Integrative Medicine. 2016 Sep .
23. Alrefaei AF, Elbeeh ME. Hepatoprotective Effects of Glycyrrhiza glabra in Diabetic Male Rats: Addressing Liver Function, Oxidative Stress, and Histopathological Changes. Biology. 2025 Mar 18
24.Jung JC, Lee YH, Kim SH, Kim KJ, Kim KM, Oh S, et al. Hepatoprotective effect of licorice, the root of Glycyrrhiza uralensis Fischer, in alcohol-induced fatty liver disease. BMC Complementary and Alternative Medicine. 2015 Dec
25. Huang CZ, Tung YT, Hsia SM, Wu CH, Yen GC. The hepatoprotective effect of Phyllanthus emblica L. fruit on high fat diet-induced non-alcoholic fatty liver disease (NAFLD) in SD rats. Food & Function 2017 Feb 23 [cited 2020 Oct 7];8(2):842–50.
26.Luo X, Zhang B, Pan Y, Gu J, Tan R, Gong P. Phyllanthus emblica aqueous extract retards hepatic steatosis and fibrosis in NAFLD mice in association with the reshaping of intestinal microecology.
27. Saraswat I, Goel A, Gupta J. Herbal remedies for hepatic diseases: A review of medicinal herbs in the treatment of liver disorders. Chinese Herbal Medicines. 2026 Apr;18
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.